JPGSX
Price
$76.98
Change
+$7.96 (+11.53%)
Updated
Apr 9 closing price
Net Assets
1.46B
VIGIX
Price
$189.51
Change
+$20.34 (+12.02%)
Updated
Apr 9 closing price
Net Assets
260.76B
Ad is loading...

JPGSX vs VIGIX

Header iconJPGSX vs VIGIX Comparison
Open Charts JPGSX vs VIGIXBanner chart's image
JPMorgan U.S. GARP Equity I
Price$76.98
Change+$7.96 (+11.53%)
VolumeN/A
Net Assets1.46B
Vanguard Growth Index Institutional
Price$189.51
Change+$20.34 (+12.02%)
VolumeN/A
Net Assets260.76B
JPGSX vs VIGIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JPGSX vs. VIGIX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JPGSX is a Buy and VIGIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIGIX has more cash in the bank: 261B vs. JPGSX (1.46B). VIGIX pays higher dividends than JPGSX: VIGIX (0.52) vs JPGSX (0.16). JPGSX was incepted earlier than VIGIX: JPGSX (22 years) vs VIGIX (27 years). JPGSX (0.65) is less costly to investors than VIGIX (0.04). JPGSX is a more actively managed with annual turnover of: 46.00 vs. VIGIX (5.00). JPGSX has a lower initial minimum investment than VIGIX: JPGSX (1000000) vs VIGIX (5000000). VIGIX annual gain was more profitable for investors over the last year : -4.20 vs. JPGSX (-10.72). VIGIX return over 5 years is better than : 96.03 vs. JPGSX (39.20).
JPGSXVIGIXJPGSX / VIGIX
Total Expense Ratio0.590.041,475%
Annual Report Gross Expense Ratio0.650.041,625%
Fund Existence22 years27 years-
Gain YTD-19.651-19.91299%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets1.46B261B1%
Annual Yield % from dividends0.160.5231%
Returns for 1 year-10.72-4.20255%
Returns for 3 years11.4117.9064%
Returns for 5 years39.2096.0341%
Returns for 10 years73.07201.8436%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RGNX5.890.58
+10.92%
REGENXBIO
KPTI4.300.34
+8.46%
Karyopharm Therapeutics Inc.
ANGI12.981.01
+8.40%
Angi Inc
NSC222.0215.68
+7.60%
Norfolk Southern Corp
LU2.580.13
+5.31%
Lufax Holding Ltd